BNET Industries
Market Cap:$4.1B
Last Fiscal Year Sales:$2.5B
- Public
- US
Dow Jones Description
Watson Pharmaceuticals, Inc. is a global leader in the development and distribution of pharmaceuticals with a broad portfolio of generic products and a specialized portfolio of branded pharmaceuticals focused on Urology, Gynecology and Nephrology (Medical).
Number of Employees 5,070
Contact Information
311 Bonnie Cir
PO Box 1900
Corona, California 92880
(951) 270-1400
Peer Companies
NAICS Code Pharmaceutical Preparation Manufacturing: 325412
Recent Events
-
Piper Jaffray Initiates Coverage on Watson Pharmaceuticals WPI with an Underweight; Hard to Envision Significant...
-
Takeda Sues Watson Over Generic Rozerem ANDA
-
FTC Proposes Asset Divestiture in Watson Acquisition of Arrow
-
Watson Completes Acquisition of Arrow Group
-
Trubion CEO out in management shuffle
-
Week of Nov. 16, 2009: GSK and Nabi Form Nicotine Vaccine Agreement; Eli Lilly Research...
-
Watson Pharmaceuticals: Income Statement Analysis for the September 2009 Quarter
-
Watson Pharmaceuticals names new senior vice president and CFO
-
UPDATE 1-Watson names R. Todd Joyce as new CFO
News & Analysis
Filter by
government and watson pharmaceuticals inc. - All News and Analysis
Watson Pharmaceuticals, Inc. Q2 2009 Earnings Call Transcript
Seeking Alpha
- 2009-07-29
Question-and-Answer SessionOperator Operator instructions Your first question comes from Randall Stanicky from Goldman Sachs. Bob - Goldman Sachs Hi, good morning guys. This is actually Bob [ph] on for Randall this morning. Paul just quickly on the guidance, I guess could you may be help us understand, what gives...
Watson Pharmaceuticals, Inc. Q4 2008 Earnings Call Transcript
Seeking Alpha
- 2009-02-19
Question-and-Answer SessionOperator Operator instructions We’ll pause for just a moment to compile the Q&A roster. Your question comes from Greg Gilbert with Bank of America. Paul Bisaro Hey, Greg. Greg Gilbert – Bank of America Hey, thanks. Good morning. Paul, you slipped in a comment about pricing improving, given...
Significant Double Digit Moves Over 70% Following News.
- 2002-03-28
VANCOUVER, BRITISH COLUMBIA, Mar 28, 2002 Among the wide range of North American stocks available to EquityAlert.com's news alert subscribers, a FREE service available at www.equityalert.com, was Aksys, Ltd. (NASDAQ: AKSY), a pioneer in innovative dialysis systems, announcing Wednesday that the Company received...
- 1
Industry Transcripts by Seeking Alpha
-
Peregrine Pharmaceuticals Inc. F2Q10 (Qtr End 31/10/09) Earnings Call Transcript
on Dec 10, 2009about PPHM
-
Avanir Pharmaceuticals F4Q09 (Qtr End 09/30/2009) Earnings Call Transcript
on Nov 24, 2009about AVNR
-
Palatin Technologies F1Q10 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 16, 2009about PTN
-
Flamel Technologies SA Q3 2009 Earnings Call Transcript
on Nov 16, 2009about FLML
-
NexMed Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about NEXM
Glass Door
Watson Pharmaceuticals
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- More Tysabri Problems; Time for a Biogen-Idec Credibility Check 3 votes
- Fired Whistleblower Reps Make Similar Claim: Pfizer Said They Lacked "Integrity" 3 votes
- BioCryst's Antiviral Drug Peramivir Aims to Keep Swine-Flu Body Count Low 3 votes
- Why J&J's Stelara Launch Should Target Dermatologists First 3 votes
Presented by American Express